| David H. Mack, Ph.D. | President, Chief Executive Officer and Director | FY2025 | |
| Deepika Jalota, Pharm.D. | Chief Development Officer | FY2025 | |
| Robert Ticktin | General Counsel & Chief Operating Officer | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.